Foundry Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$255K Buy
277
+82
+42% +$83.1K 0.13% 54
2025
Q4
$210K Buy
+195
New +$186K 0.1% 61

Other funds holding LLY

Foundry Financial Group's LLY Position: Q1 2026 in Review

Foundry Financial Group increased its Eli Lilly (LLY) stake by 42% in Q1 2026, buying an estimated $83.1K and bringing the position to 277 shares worth $255K. The position accounts for 0.13% of the portfolio, ranked #54.

Foundry Financial Group first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Foundry Financial Group held 277 shares of Eli Lilly worth $255K as of Q1 2026.
  • Foundry Financial Group bought 82 Eli Lilly shares in Q1 2026, an estimated $83.1K.
  • Eli Lilly made up 0.13% of Foundry Financial Group's portfolio in Q1 2026, its #54 holding.
  • Foundry Financial Group first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Foundry Financial Group's 13F filing for Q1 2026, filed 23 Apr 2026.